Inhibitory action of carvedilol, a novel α,β-adrenoceptor antagonist, on catecholamine secretion and calcium influx in cultured bovine adrenal chromaffin cells-Reference-Cited by-同舟云学术

Inhibitory action of carvedilol, a novel α,β-adrenoceptor antagonist, on catecholamine secretion and calcium influx in cultured bovine adrenal chromaffin cells

Published:1989-12 Issue:24 Volume:38 Page:4461-4465
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Kyoji Morita,Shuichi Hamano,Masanori Yoshizumi,Motoo Oka

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference17 articles.

1. Acute hypotensive response to the new antihypertensive agent (BM 14,190) in essential hypertensive patients;Meyer-Sabellek;J Hypertens,1983

2. Haemodynamic effects of carvedilol, a new betaadrenoceptor blocker and precapillary vasodilator in essential hypertension;Eggertsen;J Hypertens,1984

3. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension;Ogihara;J Cardiovasc Pharmacol,1987

4. Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties in exercise induced ischemia;Kaski;Am J Cardiol,1985

5. Pharmacological profile of carvedilol as a β-blocking agent with vasodilating and hypotensive properties;Sponer;J Cardiovasc Pharmacol,1987

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocardial infarction, heart failure and sympathetic nervous system activity: new pharmacological approaches that affect neurohumoral activation;Expert Opinion on Investigational Drugs;2008-08-12

2. Carvedilol;Comprehensive Medicinal Chemistry II;2007

3. Inhibitory Effects of Carvedilol on Calcium Channels in Vascular Smooth Muscle Cells.;Japanese Heart Journal;2003

4. Differential Effects of Short and Prolonged Exposure to Carvedilol on Voltage-Dependent Na+Channels in Cultured Bovine Adrenal Medullary Cells;Journal of Pharmacology and Experimental Therapeutics;2002-07-01

5. Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity;Biochemical Pharmacology;1999-12